TA
MYGN icon

Teton Advisors’s Myriad Genetics MYGN Stock Holding History

Teton Advisors’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-13,600
Closed -$492K – 430
2017
Q3 		$492K Sell
13,600
-5,100
-27% -$145K 0.05% 306
2017
Q2 		$483K Hold
18,700
– – 0.05% 308
2017
Q1 		$359K Hold
18,700
– – 0.04% 336
2016
Q4 		$312K Buy
+18,700
New +$338K 0.03% 338

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Teton Advisors's MYGN Position: Q4 2017 in Review

Teton Advisors sold out of Myriad Genetics (MYGN) in Q4 2017, closing a stake of 13,600 shares — an estimated $492K sold.

Teton Advisors first reported a position in MYGN in Q4 2016 and held it in 4 quarters. The position peaked at $492K in Q3 2017. 250 funds tracked by Wall St. Rank hold MYGN as of Q4 2017.

  • Teton Advisors reported no remaining Myriad Genetics position as of Q4 2017 after selling out during the quarter.
  • Teton Advisors sold 13,600 Myriad Genetics shares in Q4 2017, an estimated $492K.
  • Teton Advisors first reported a position in Myriad Genetics in Q4 2016 and held it in 4 quarters.
  • Teton Advisors's Myriad Genetics position peaked at $492K in Q3 2017.
  • 250 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2017.

Based on Teton Advisors's 13F filing for Q4 2017, filed 2 Feb 2018.